resources

De-risking Formulation Development: Using the MacroFLUX System to Predict Human Outcomes of KinetiSol Processed Etravirine

De-risking Formulation Development: Using the MacroFLUX System to Predict Human Outcomes of KinetiSol Processed Etravirine

Case Study

Preview - This content has been restricted to logged in users only.

See how FLUX + Predictor combines dissolution-permeation testing and mechanistic modeling to predict oral absorption and assess formulation performance.
De-risking Formulation Development: Using the MacroFLUX System to Predict Human Outcomes of KinetiSol Processed Etravirine

Case Study

Explore how integrated dissolution-permeation testing and mechanistic in silico modeling can improve predictions of in vivo oral absorption. This application note features Predictor™  absorption model, along with validation and case studies using MicroFLUX™ and BioFLUX™, demonstrating how the combined approach can support bioequivalence assessment and help evaluate the impact of formulation changes on in vivo performance.

Previous post